Empresa
Mineralys Therapeutics
Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.
Mineralys is a fully remote company.
For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.
Vacantes abiertas
140
activas ahora
Nuevas hoy
23
últimas 24 horas
Remoto mundial
0
desde cualquier lugar
Departamentos
11
contratando en
No hay vacantes que coincidan
Ninguna vacante abierta en Mineralys Therapeutics coincide con estos filtros ahora mismo.